Ignite Creation Date:
2024-05-06 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05782127
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-02-23
Brief Title:
Oral Azacitidine Combined with Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Groupe Francophone des Myelodysplasies
Organization Data
Organization:
Groupe Francophone des Myelodysplasies
Class:
OTHER
Study ID:
GFM-ONUVEN-MDS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| AbbVie | INDUSTRY |